Jeffrey S. Wiseman
Plus aucun poste en cours
Profil
Jeffrey S.
Wiseman is Vice President of Technology and Informatics for Locus Pharmaceuticals, Inc. Prior to joining Locus Pharmaceuticals June 2003, he was Global Vice President of Cheminformatics for GlaxoSmithKline, Inc. Dr. Wiseman held various management positions in research computing and molecular sciences at Glaxo Wellcome and SmithKline Beecham.
He started his career at the Merrell Dow Research Institute and served as a Group Leader of Enzyme Chemistry.
Dr. Wiseman trained as a Postdoctoral Research Fellow at Stanford University and Brandeis University.
He has 24 years of experience in the pharmaceutical industry.
Dr. Wiseman received a BS degree in Chemistry from Ohio University and a PhD in Chemistry from Harvard University.
Anciens postes connus de Jeffrey S. Wiseman
| Sociétés | Poste | Fin |
|---|---|---|
| Brandeis University | Corporate Officer/Principal | - |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | - |
| Stanford University | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Formation de Jeffrey S. Wiseman
| Harvard University | Doctorate Degree |
| The Ohio University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GSK PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
